Superbugs Onslaught: A Novel Paradigm in Wound Care

• Superbugs

Emergence of superbugs results from bacteria developing resistance to antimicrobial agents, posing a significant health threat. Recent international news highlighted the case of a 29-year-old woman succumbing to organ failure within two weeks of contracting a superbug infection. Identified as MRSA (Methicillin-Resistant Staphylococcus Aureus), it underscores the urgency of addressing antimicrobial resistance globally.

• Daily Concealed Risks

While showering is a routine practice for most individuals, a foreign female doctor has directly pointed out that the consequences of inadequate bathing extend beyond mere cleanliness. There is even a risk of infection by the superbug "MRSA." Overlooked areas prone to harboring dirt include behind the ears, the belly button, and nail crevices.

• MRSA

MRSA, or Methicillin-Resistant Staphylococcus Aureus, is unique in that it resides harmlessly on the surface of the skin, yet when it enters the body through a wound, it can have adverse effects, potentially leading to multiple organ failure and death in severe cases.

• Common Antibiotic-Resistant Bacteria: Staphylococcus aureus

Staphylococcus aureus, commonly found on the skin, hair, mucous membranes, and in feces, can opportunistically proliferate in damaged skin or contaminated food. Infection, presenting as pustules, blisters, and skin swelling, requires thorough wound cleaning, antibiotic treatment, and proper dressing to prevent caregiver contact infections.

• Advancing Drug Research and Development

Since 2018, AMS BioteQ has prioritized microbiological and drug research, with a strong focus on combating antimicrobial resistance. Our mission is to develop antiviral medications to fight against superbugs and minimize wound infections.

• MEDIACE® Natural Antimicrobial Ingredients

MEDIACE®, the focus of AMS BioteQ's research, contains the exclusive antimicrobial formula FORMOSA-1117 antibiotic. Tested on wounds of diabetic animals by academic institutions, which demonstrates significant efficacy in promoting wound healing.

• SIPSIP Innovative Hydrophilic Dressing

After sustaining an injury, individuals often seek rapid wound healing to minimize the risk of secondary infections. AMS BioteQ addresses this need by developing the SIPSIP series of innovative hydrophilic dressings. Designed to enhance wound healing and alleviate burning discomfort, these dressings have demonstrated efficacy in mouse experiments for promoting optimal wound recovery.

Features of SIPSIP

• Non-allergenic
• Highly absorbent
• Patented wound repair technology
• Unique physical structure

Meanwhile, it has been validated through animal experiments utilizing mouse wound models, demonstrating:

• Promote wound healing
• Functional tissue regeneration effects

This product has been successively completed FDA, TFDA and patent applications, and will soon be marketed to provide more diversified choices for the medical and patient population.

• Chairman Dr. George Tsai remarked, "Superbugs may usher humanity into a dark era, reminiscent of times when minor infections proved fatal." Amidst the current prevalence of superbugs, he hopes to offer professional assistance, providing medical communities with a diverse array of choices.

#botanicaldrug #medicinalfungi #herbalmedicine #smallmoleculedrug #braodspectrumantibiotics #postcovid